Physician

Eric Adrian Awad, MD

According to 2025 Medicare claims, Eric Awad, MD (NPI: 1578557500) practices neurology in the Marietta, GA market, with the plurality of this provider's patient population coming from Cherokee, GA. This provider's primary affiliated billing organization is ERIC A. AWAD MD,LLC (NPI: 1275694317; TIN: 582585832) and primary practice location at 30309-1407.

Awad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 274 traditional Medicare patients, billed 87,297 HCPCS/CPT codes, and received $780,946 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,254 prescription claims across 420 beneficiaries totaling $2,617,360 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). DME data shows 77 claims. Open Payments data shows 205 records totaling $34,290. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $106,523 to $780,946. Similarly, Part D prescription costs have risen steadily, from $1,189,286 to $2,617,360. In contrast, DME billing represents a smaller volume and rose steadily, from $3,965 to $36,738.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	521	3,364	$106,523
2016	506	5,050	$111,429
2017	542	7,539	$158,794
2018	490	13,738	$325,790
2019	368	17,516	$391,654
2020	316	23,334	$1,026,112
2021	341	21,160	$1,098,830
2022	348	25,059	$1,149,289
2023	348	35,528	$875,725
2024	274	87,297	$780,946

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	390	3,510	$1,189,286
2016	407	3,655	$1,198,341
2017	442	3,653	$1,449,358
2018	455	3,414	$1,746,600
2019	405	3,081	$1,605,521
2020	376	2,904	$1,755,806
2021	387	2,696	$2,022,883
2022	408	2,828	$1,819,960
2023	443	3,178	$1,766,179
2024	420	3,254	$2,617,360

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	23	$498
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	39	$75,220
2022	N/R	39	$75,044
2023	N/R	46	$79,077
2024	N/R	77	$150,254

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	26	26	$144
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	30	30	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	92	127	$90
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	18	30	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	191	303	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	80	1,977	$567,795
Wakix	Pitolisant Hcl	12	360	$195,524
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	18	490	$183,117
Kesimpta Pen	Ofatumumab	11	308	$94,466
Glatopa	Glatiramer Acetate	20	568	$46,158

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$69,003
J7340	Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml	N	N/R	13	$65,943
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	13	$13,306
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	25	$1,868
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	13	$134

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	204	$33,960	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$330	IDORSIA PHARMACEUTICALS US INC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eric Adrian Awad, MD?

Tedicare shows public-source Medicare data for Eric Adrian Awad, MD (NPI 1578557500), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric Adrian Awad, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Eric Adrian Awad, MD?

Eric Adrian Awad, MD is linked to ERIC A. AWAD MD,LLC (billing NPI 1275694317) in the available physician profile data.

Does Eric Adrian Awad, MD have Open Payments data?

Eric Adrian Awad, MD has 205 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.